This site is intended for healthcare professionals
Latest industry news

Wisamt N

Last updated: 8th Dec 2025
Published: 8th Dec 2025
Author: Megan Lee

Wisamt N was a topical combination acne treatment containing:

  • Resorcinol
  • Sulfur

It was used for:

  • Treatment of mild to moderate acne
  • Reduction of excess oil and keratolytic action to unclog pores
  • Support in managing comedones and inflammatory lesions

Wisamt N is not currently authorized or marketed in the USA or EU, as reflected by its absence from U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) databases. It was previously manufactured by Procter & Gamble but is now discontinued.

By Megan Lee

Developed by EPG Health for Medthority, independently of any sponsor.

Welcome:

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

How do you prefer to access medical updates and information?

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.